491
Views
6
CrossRef citations to date
0
Altmetric
Review

Pharmacokinetic considerations about antiseizure medications in the elderly

, , , , , , , , ORCID Icon & show all
Pages 983-995 | Received 18 Jun 2020, Accepted 03 Aug 2020, Published online: 25 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Gaetano Zaccara, Simona Lattanzi & Emilio Russo. (2021) Pharmacokinetic drug interactions between antiseizure medications and drugs for comorbid diseases in children with epilepsy. Expert Opinion on Drug Metabolism & Toxicology 17:5, pages 595-610.
Read now

Articles from other publishers (5)

Armel Stockis, Jean‐Marie Nicolas, Maria Laura Sargentini‐Maier & Walter Krauwinkel. (2023) Pharmacokinetics, Safety, and Tolerability of Brivaracetam in Healthy Elderly Participants. Clinical Pharmacology in Drug Development 12:11, pages 1121-1127.
Crossref
Leanne M. Lehmann & Melissa Barker-Haliski. (2023) Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model. Frontiers in Neurology 14.
Crossref
Naoto Nagino, Yuichi Kubota, Hidetoshi Nakamoto, Satoru Miyao, Tomohiro Kodama, Susumu Ito, Hirokazu Oguni & Mikhail Chernov. (2022) Non-lesional late-onset epilepsy in the elderly Japanese patients: Presenting characteristics and seizure outcomes with regard to comorbid dementia. Journal of Clinical Neuroscience 103, pages 100-106.
Crossref
David Liang, Elena Gardella, Kristian Kragholm, Christoffer Polcwiartek & Maurizio Sessa. (2022) The Relationship Between Valproate and Lamotrigine/Levetiracetam Use and Prognosis in Patients With Epilepsy and Heart Failure: A Danish Register-Based Study. Journal of Cardiac Failure 28:4, pages 630-638.
Crossref
Benjamin Cretin. (2020) Treatment of Seizures in Older Patients with Dementia. Drugs & Aging 38:3, pages 181-192.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.